<?xml version="1.0" encoding="UTF-8"?><abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>http://api.elsevier.com/content/abstract/scopus_id/84887455017</prism:url><dc:identifier>SCOPUS_ID:84887455017</dc:identifier><eid>2-s2.0-84887455017</eid><pubmed-id>24144909</pubmed-id><prism:doi>10.1016/j.neuropharm.2013.09.028</prism:doi><dc:title>Probing the non-canonical interface for agonist interaction with an α5 containing nicotinic acetylcholine receptor</dc:title><prism:aggregationType>Journal</prism:aggregationType><srctype>j</srctype><citedby-count>2</citedby-count><prism:publicationName>Neuropharmacology</prism:publicationName><dc:publisher>
Elsevier Ltd
</dc:publisher><source-id>20435</source-id><prism:issn>18737064</prism:issn><prism:volume>77</prism:volume><prism:startingPage>342</prism:startingPage><prism:endingPage>349</prism:endingPage><prism:pageRange>342-349</prism:pageRange><prism:coverDate>2014-01-01</prism:coverDate><dc:creator><author auid="55925366800" seq="1"><ce:initials>C.B.</ce:initials><ce:indexed-name>Marotta C.B.</ce:indexed-name><ce:surname>Marotta</ce:surname><ce:given-name>Christopher B.</ce:given-name><preferred-name>
<ce:initials>C.B.</ce:initials>
<ce:indexed-name>Marotta C.</ce:indexed-name>
<ce:surname>Marotta</ce:surname>
<ce:given-name>Christopher B.</ce:given-name>
</preferred-name><author-url>http://api.elsevier.com/content/author/author_id/55925366800</author-url></author></dc:creator><dc:description><abstract original="y" xml:lang="eng">
<ce:para>Nicotinic acetylcholine receptors (nAChRs) containing the α5 subunit are of interest because genome-wide association studies and candidate gene studies have identified polymorphisms in the α5 gene that are linked to an increased risk for nicotine dependence, lung cancer, and/or alcohol addiction. To probe the functional impact of an α5 subunit on nAChRs, a method to prepare a homogeneous population of α5-containing receptors must be developed. Here we use a gain of function (9′) mutation to isolate populations of α5-containing nAChRs for characterization by electrophysiology. We find that the α5 subunit modulates nAChR rectification when co-assembled with α4 and β2 subunits. We also probe the α5-α4 interface for possible ligand-binding interactions. We find that mutations expected to ablate an agonist-binding site involving the α5 subunit have no impact on receptor function. The most straightforward interpretation of this observation is that agonists do not bind at the α5-α4 interface, in contrast to what has recently been demonstrated for the α4-α4 interface in related receptors. In addition, our mutational results suggest that the α5 subunit does not replace the α4 or β2 subunits and is relegated to occupying only the auxiliary position of the pentameric receptor. © 2013 Elsevier Ltd. All rights reserved.</ce:para>
</abstract></dc:description><link href="http://api.elsevier.com/content/abstract/scopus_id/84887455017" rel="self"/><link href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84887455017&amp;origin=inward" rel="scopus"/><link href="http://api.elsevier.com/content/search/scopus?query=refeid%282-s2.0-84887455017%29" rel="cited-by"/></coredata><authors><author auid="55925366800" seq="1"><ce:initials>C.B.</ce:initials><ce:indexed-name>Marotta C.B.</ce:indexed-name><ce:surname>Marotta</ce:surname><ce:given-name>Christopher B.</ce:given-name><preferred-name>
<ce:initials>C.B.</ce:initials>
<ce:indexed-name>Marotta C.</ce:indexed-name>
<ce:surname>Marotta</ce:surname>
<ce:given-name>Christopher B.</ce:given-name>
</preferred-name><author-url>http://api.elsevier.com/content/author/author_id/55925366800</author-url></author><author auid="55336489000" seq="2"><ce:initials>C.N.</ce:initials><ce:indexed-name>Dilworth C.N.</ce:indexed-name><ce:surname>Dilworth</ce:surname><ce:given-name>Crystal N.</ce:given-name><preferred-name>
<ce:initials>C.N.</ce:initials>
<ce:indexed-name>Dilworth C.</ce:indexed-name>
<ce:surname>Dilworth</ce:surname>
<ce:given-name>Crystal N.</ce:given-name>
</preferred-name><author-url>http://api.elsevier.com/content/author/author_id/55336489000</author-url></author><author auid="7102915571" seq="3"><ce:initials>H.A.</ce:initials><ce:indexed-name>Lester H.A.</ce:indexed-name><ce:surname>Lester</ce:surname><ce:given-name>Henry A.</ce:given-name><preferred-name>
<ce:initials>H.A.</ce:initials>
<ce:indexed-name>Lester H.</ce:indexed-name>
<ce:surname>Lester</ce:surname>
<ce:given-name>Henry A.</ce:given-name>
</preferred-name><author-url>http://api.elsevier.com/content/author/author_id/7102915571</author-url></author><author auid="7101912629" seq="4"><ce:initials>D.A.</ce:initials><ce:indexed-name>Dougherty D.A.</ce:indexed-name><ce:surname>Dougherty</ce:surname><ce:given-name>Dennis A.</ce:given-name><preferred-name>
<ce:initials>D.A.</ce:initials>
<ce:indexed-name>Dougherty D.</ce:indexed-name>
<ce:surname>Dougherty</ce:surname>
<ce:given-name>Dennis A.</ce:given-name>
</preferred-name><author-url>http://api.elsevier.com/content/author/author_id/7101912629</author-url></author></authors></abstracts-retrieval-response>
